Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)

Clinical trial NCT05170269 · TERMINATED

Trial details

NCT number: NCT05170269
Sponsor: Biotest
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Cytomegalovirus Infection

Start date: 2021-11-17
Primary completion: 2023-11-19
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.